OncoCyte (OCX)
(Delayed Data from NSDQ)
$3.24 USD
+0.07 (2.05%)
Updated Jul 23, 2024 03:59 PM ET
After-Market: $3.22 -0.02 (-0.46%) 4:24 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Earnings News For OCX
-
OncoCyte: Q1 Earnings Snapshot
-
Oncocyte Reports First Quarter 2024 Financial Results
-
OncoCyte: Q3 Earnings Snapshot
-
Oncocyte Reports Third Quarter 2023 Financial Results
-
OncoCyte: Q2 Earnings Snapshot
-
OncoCyte: Q1 Earnings Snapshot
-
Oncocyte Reports First Quarter 2023 Financial Results
-
Oncocyte Reports Preliminary Fourth Quarter and Full Year 2022 Financial Results and Plans to File Form 12b-25 to Extend Filing Date of Its Form 10-K
-
Oncocyte Announces Date Change for Fourth Quarter and Full Year 2022 Earnings Call
-
OncoCyte (OCX) Reports Q3 Loss, Misses Revenue Estimates
-
OncoCyte: Q3 Earnings Snapshot
-
Oncocyte Reports Third Quarter 2022 Financial Results
-
OncoCyte: Q2 Earnings Snapshot
-
OncoCyte (OCX) Reports Q2 Loss, Misses Revenue Estimates
-
OncoCyte (OCX) Reports Q1 Loss, Lags Revenue Estimates
-
OncoCyte (OCX) Q4 Earnings Match Estimates, Revenues Lag (Revised)
-
OncoCyte (OCX) Reports Q4 Loss, Lags Revenue Estimates
-
OncoCyte (OCX) Reports Q3 Loss, Lags Revenue Estimates
-
Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know
-
OncoCyte (OCX) Reports Q2 Loss, Tops Revenue Estimates
-
Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know
-
Will OncoCyte (OCX) Report Negative Q1 Earnings? What You Should Know
-
OncoCyte (OCX) Reports Q4 Loss, Misses Revenue Estimates
-
OncoCyte (OCX) Reports Q2 Loss, Tops Revenue Estimates